scholarly article | Q13442814 |
P2093 | author name string | Kellie R Brown | |
Brian D Lewis | |||
Charles E Edmiston | |||
Gary R Seabrook | |||
Christopher P Johnson | |||
Jonathan B Towne | |||
Michael P Goheen | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 344-354 | |
P577 | publication date | 2006-09-01 | |
P1433 | published in | The American Journal of Surgery | Q15762745 |
P1476 | title | Impact of selective antimicrobial agents on staphylococcal adherence to biomedical devices. | |
P478 | volume | 192 |
Q30240106 | A narrative review of microbial biofilm in postoperative surgical site infections: clinical presentation and treatment |
Q41641430 | Antibiofilm Effect of Octenidine Hydrochloride on Staphylococcus aureus, MRSA and VRSA. |
Q89551956 | Antibiotic Delivery Strategies to Treat Skin Infections When Innate Antimicrobial Defense Fails |
Q33588266 | Antibiotic susceptibility of coagulase-negative staphylococci isolated from very low birth weight babies: comprehensive comparisons of bacteria at different stages of biofilm formation |
Q38378865 | Approach to chronic wound infections |
Q35941476 | Daptomycin and tigecycline have broader effective dose ranges than vancomycin as prophylaxis against a Staphylococcus aureus surgical implant infection in mice |
Q38282725 | Daptomycin antibiotic lock therapy in a rat model of staphylococcal central venous catheter biofilm infections |
Q42743421 | Daptomycin for the treatment of Gram-positive microorganisms in the critically-ill patient |
Q45256369 | Daptomycin in diabetic patients |
Q58914846 | Daptomycin: local application in implant-associated infection and complicated osteomyelitis |
Q42103662 | Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model. |
Q35296773 | Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus. |
Q36916068 | Epidemiology of staphylococcal resistance |
Q33726771 | Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin |
Q37263546 | In vitro efficacies and resistance profiles of rifampin-based combination regimens for biofilm-embedded methicillin-resistant Staphylococcus aureus |
Q39634407 | Inactivation of Acinetobacter baumannii Biofilms on Polystyrene, Stainless Steel, and Urinary Catheters by Octenidine Dihydrochloride |
Q37971165 | Infections in vascular surgery |
Q37932891 | Microbial pathogenesis of bacterial biofilms: a causative factor of vascular surgical site infection |
Q40018152 | New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection |
Q60609665 | Novel fatty acid gentamicin salts as slow-release drug carrier systems for anti-infective protection of vascular biomaterials |
Q42231206 | Oral antibiotic therapy |
Q44287031 | Successful salvage of peritoneal catheter in unresolved methicillin-resistant staphylococcus aureus peritonitis by combination treatment with daptomycin and rifampin |
Q36866209 | Surgical site and vascular infections: treatment and prophylaxis |
Q41755464 | Tolerability of High Doses of Daptomycin in the Treatment of Prosthetic Vascular Graft Infection: A Retrospective Study |
Q36791058 | Use of pharmacodynamic principles to optimise dosage regimens for antibacterial agents in the elderly |
Q37041345 | Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat model |
Q84028219 | [Daptomycin in outpatient antimicrobial parenteral therapy] |